IPHA News
September 26, 2022
In the coming weeks, the Government will publish a White Paper on Enterprise. It will explore strategic policy options facing the enterprise sector. It comes as […]
September 14, 2022
Biogen’s Michael O’Connell named as new IPHA President Takeda’s Shane Ryan confirmed as Vice-President as industry focuses on a better environment for access, competitiveness and innovation […]
July 4, 2022
Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA Half of people believe Covid-19 pandemic will eventually end while […]
June 20, 2022
Sustained funding and an agile reimbursement system can improve care standards, writes Jim McGrath The reason medicines are reimbursed is that they improve the standard […]
June 20, 2022
Over half the public has favourable opinion about pharmaceutical industry, says Ipsos survey for IPHA Latest research shows public values science and the industry’s local societal […]
June 20, 2022
Irish patients deserve faster access to the best new medicines. We are slower than almost every other western European country to give the latest medicines to […]
June 19, 2022
A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped to 22%. The United States has […]
May 23, 2022
More process efficiency urged as data shows Finland and Denmark outperform Ireland in drawing research activity Ireland is attracting fewer clinical trials than some European countries […]
May 11, 2022
Global equity of access to Covid-19 vaccines should be a shared goal, according to the research-based biopharmaceutical industry, with production set to reach 16.3 billion doses by […]